Other Events ·
POMDOCTOR Limited announced it will participate in the 28th Annual H.C. Wainwright Global Investment Conference…
POMPOMDOCTOR Ltd
POMDOCTOR Limited announced it will participate in the 28th Annual H.C. Wainwright Global Investment Conference, scheduled for September 14-16, 2026, with a pre-recorded presentation available starting September 11, 2026. Chairman and CEO Zhenyang Shi and COO Wanmei Shi will hold one-on-one investor meetings. The accompanying investor presentation outlines the company's strategy to build a predictive healthcare data infrastructure leveraging AI, wearables, and real-world data. Key operating metrics include over 212,800 partner physicians, nearly 700,000 paying patients, and more than 3.13 million prescriptions processed. The presentation details a plan to raise US$30 million for U.S. market expansion, AI infrastructure, and wearable device production, targeting a formal U.S. launch at CES in January 2027. Financial highlights show FY2025 net revenues of RMB 399.9 million and a net loss of RMB 130.9 million. POMDOCTOR Limited is a digital healthcare company focused on advancing AI-enabled healthcare solutions.